Sirnaomics Ltd Partners with Edirna Inc. to Advance RNA Editing Therapy
Sirnaomics Ltd (HKG: 2257), a leading company in the field of RNA therapeutics, has announced...
Sirnaomics Ltd (HKG: 2257), a leading company in the field of RNA therapeutics, has announced...
Sino Biopharmaceutical Ltd (HKG: 1177) has announced a third licensing agreement between its subsidiary, F-star...
China-based Tot Biopharma International Co., Ltd (HKG: 1875) has announced a strategic partnership with compatriot...
China-based Biocytogen Pharmaceuticals (Beijing) Co., Ltd (HKG: 2315) has announced an antibody license agreement with...
Nanjing Kati Medical Technology Co., Ltd, a China-based company, has entered into a partnership with...
China-based Brii Biosciences Ltd (HKG: 2137) has announced an expanded license agreement with US firm...
China-based Jacobio Pharma (HKG: 1167) has announced the cancellation of a licensing agreement with US...
Wuhan-based Binhui Biopharmaceutical and Hubei Topgene Biotechnology Co., Ltd have announced a strategic partnership to...
The South China Morning Post reports that the local government in Shanghai’s Huangpu district has...
Sinotau Pharmaceutical Group, a prominent nuclear medicine (radiopharmaceutical) company headquartered in Beijing, has reportedly raised...
Sisram Medical Ltd (HKG: 1696), an Israel-based company and part of the Fosun Pharmaceutical Group...
Beijing Sun-Novo Pharmaceutical Research Co., Ltd (SHA: 688621) has announced a significant licensing agreement with...
Cornerstone Robotics, a leading surgical robot developer based in Shenzhen, has reportedly raised RMB 800...
Germany-based Merck KGaA (NYSE: MRK) has announced plans to expand production capacity for highly-purified reagents...
Shanghai Pharmaceuticals Holding Co., Ltd’s (SHA: 601607, HKG: 2607) subsidiary, MediTrust Health, which specializes in...
Chengdu-based mRNA specialist WestGene Biopharma has reportedly raised USD 42 million via a funding round,...
US pharmaceutical major Pfizer (NYSE: PFE) has entered into a partnership with China-based CSPC Pharmaceutical...
China-based Changchun BCHT Biotechnology Co., Ltd (SHA: 688276) has announced its intention to invest in...
Worg Pharmaceuticals, a Hangzhou-based developer of allergy drugs, has reportedly raised RMB 1.1 billion (USD...
Sichuan Kelun Pharmaceutical Co., Ltd’s (SHE: 002422) innovative drug development subsidiary, Sichuan Kelun-Biotech Biopharmaceutical Co.,...